DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.22
-0.10 (-1.58%)
At close: Apr 28, 2026, 4:00 PM EDT
6.22
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
DiaMedica Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 9.78 | 7.62 | 8.16 | 6.16 | 4.88 | |
| Research & Development | 24.61 | 19.06 | 13.11 | 7.84 | 8.77 | |
| Operating Expenses | 34.4 | 26.68 | 21.27 | 14 | 13.65 | |
| Operating Income | -34.4 | -26.68 | -21.27 | -14 | -13.65 | |
| Interest & Investment Income | 1.66 | 2.27 | 1.93 | 0.35 | - | |
| Other Non Operating Income (Expenses) | - | - | - | - | 0.08 | |
| EBT Excluding Unusual Items | -32.74 | -24.41 | -19.34 | -13.65 | -13.56 | |
| Pretax Income | -32.74 | -24.41 | -19.34 | -13.65 | -13.56 | |
| Income Tax Expense | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | |
| Net Income | -32.77 | -24.44 | -19.38 | -13.68 | -13.59 | |
| Net Income to Common | -32.77 | -24.44 | -19.38 | -13.68 | -13.59 | |
| Shares Outstanding (Basic) | 47 | 40 | 33 | 26 | 21 | |
| Shares Outstanding (Diluted) | 47 | 40 | 33 | 26 | 21 | |
| Shares Change (YoY) | 16.28% | 24.07% | 23.16% | 27.29% | 32.48% | |
| EPS (Basic) | -0.70 | -0.60 | -0.60 | -0.52 | -0.65 | |
| EPS (Diluted) | -0.70 | -0.60 | -0.60 | -0.52 | -0.65 | |
| Free Cash Flow | -29.1 | -22.1 | -18.75 | -11.59 | -12.27 | |
| Free Cash Flow Per Share | -0.62 | -0.55 | -0.58 | -0.44 | -0.59 | |
| EBITDA | -34.35 | -26.64 | -21.24 | -13.98 | -13.62 | |
| D&A For EBITDA | 0.04 | 0.04 | 0.03 | 0.03 | 0.02 | |
| EBIT | -34.4 | -26.68 | -21.27 | -14 | -13.65 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.